Belmont, CA, United States of America

Kenneth C Cundy



Average Co-Inventor Count = 5.2

ph-index = 8

Forward Citations = 1,741(Granted Patents)


Location History:

  • Pottstown, PA (US) (1992 - 1996)
  • Belmont, CA (US) (1994 - 2008)

Company Filing History:


Years Active: 1992-2008

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Kenneth C Cundy

Introduction

Kenneth C Cundy is a notable inventor based in Belmont, California. He has made significant contributions to the field of nucleotide analogs, holding a total of nine patents. His work has advanced the understanding and application of nucleotide analogs in various scientific domains.

Latest Patents

Cundy's latest patents focus on nucleotide analogs characterized by the presence of an amidate linked amino acid or an ester linked group. These groups are bonded to the phosphorus atom of phosphonate nucleotide analogs. The analogs comprise a phosphoamidate or ester bond that is hydrolyzed in vivo to yield a corresponding phosphonate nucleotide analog. Methods and intermediates for their synthesis and use are also described in his patents.

Career Highlights

Throughout his career, Kenneth C Cundy has worked with prominent companies such as Gilead Sciences, Inc. and Sterling Drug Inc. His experience in these organizations has contributed to his expertise in the field of nucleotide research and development.

Collaborations

Cundy has collaborated with notable colleagues, including Murty N Arimilli and Joseph P Dougherty. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Kenneth C Cundy's innovative work in nucleotide analogs has positioned him as a significant figure in the field of biotechnology. His contributions continue to influence research and applications in this vital area of science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…